CagriSema (Cagrilintide + Semaglutide) CagriSema is a co-formulated combination therapy containing 2.4 mg each of Cagrilintide (a long-acting amylin analog) and Semaglutide (a GLP-1 receptor agonist), administered as a single weekly subcutaneous injection
Its easy to administer, but can be moderately uncomfortable, and requires you to be mindful of skin texture like scars, moles, or stretch marks
Our prescribers will review your health, your current Mounjaro dose, and how well youve tolerated treatment so far
Our healthcare provider at Vytality Blu Health & Medspa will provide you with all the necessary supplies, and we will show you how to properly administer the injection at home
People with gastroparesis may experience: Abdominal pain Belching Feeling full immediately when eating Heartburn Nausea Poor appetite Vomiting These symptoms may lead to additional complications, including: Dehydration Difficulty controlling blood sugar levels Malnutrition Novo Nordisk has acknowledged that Wegovy can cause delayed gastric emptying
